Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hematologic Neoplasms 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Neoplasms 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1 Breast Neoplasms 1

Interventions

Carboplatin 171 Paclitaxel 129 Radiotherapy 119 Cisplatin 109 Docetaxel 93 Gemcitabine 81 Erlotinib Hydrochloride 80 Pemetrexed 78 Bevacizumab 56 Etoposide 41 pembrolizumab 36 Gefitinib 32 Vinorelbine 31 Topotecan 30 Surveys and Questionnaires 29 Irinotecan 28 Radiosurgery 21 Nivolumab 20 Drug Therapy 20 Magnetic Resonance Spectroscopy 18 Cetuximab 18 durvalumab 17 Early Intervention, Educational 17 Blood Specimen Collection 17 Surgical Procedures, Operative 16 Cyclophosphamide 16 Celecoxib 15 Ipilimumab 14 Immunohistochemistry 14 Filgrastim 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lung Neoplasms × Blood Cell Count × Clear all

NCT03749512 2018-11-21

NLCR in Prediction of the Grade of Lung Tumor.

Medical University of Silesia

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡